Ipca Laboratories (NSE:IPCALAB) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
81 GF Score
Price ₹1,685.80
GF Value ₹1,626.19
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Ipca Laboratories Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:IPCALAB vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ipca Laboratories Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Short Interest distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Short Interest falls into.


NSE:IPCALAB
81GF Score
Ipca Laboratories Ltd NSE:IPCALAB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,685.80 is trading 3.7% above its estimated GF Value™ of ₹1,626.19. GuruFocus considers Ipca Laboratories to be Fairly Valued.

Key valuation signals for NSE:IPCALAB:

  • Short Interest:
  • GF Value™: ₹1,626.19 vs. price of ₹1,685.80 (3.7% above fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
81GF Score

Get the complete analysis for NSE:IPCALAB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,685.80
Price
₹1,626.19
GF Value